TEHR vs Karpa Health: Costs, Scope and Buyer Fit

How do TEHR and Karpa Health compare as of October 22, 2026?

This table separates vendor statements from unanswered questions. “Not stated on reviewed pages” means the public evidence did not establish an answer; it does not mean the capability is unavailable. Confirm the exact product, state coverage and service obligations in a written proposal.

Which business are you trying to build?

Start by distinguishing a referral business from an independently operated brand. A referral partner introduces customers to someone else’s service. A brand owner makes more decisions about pricing, customer experience and operating relationships. An established medical office may add a new cash-pay program while retaining its own clinicians and core records system. These paths can use related infrastructure while requiring different contracts and responsibilities.

Karpa’s offers page presents affiliate, white-label and full build-out routes. TEHR’s white-label platform should be evaluated for the branded operating model you intend to run, not against a referral product with different economics. Write down who owns the domain, processor account, customer communications and service agreements. Then confirm the clinical entity and pharmacy responsibilities separately. An attractive entry point is only useful if the operating model still fits when you have recurring customers, additional programs and a team managing the business.

How do two no-revenue-share models differ?

A zero-percentage headline removes one type of fee, but it does not reveal the full cost structure. Define the subscription, implementation charge, transaction event, clinical encounter fees, medication costs, shipping, labs and optional services. Some charges may be pass-through expenses rather than margin for the platform. Those differences matter because the operator still pays them, even when the vendor does not mark them up.

Karpa’s published offers start at $297 per month and describe pass-through costs; a setup amount requires a quote. TEHR uses a flat subscription plus a flat transaction fee and 0% revenue share; request a scoped TEHR quote. Put the proposals into the same operating model. Use realistic customer retention, failed payments and follow-up demand rather than assuming every patient generates one identical transaction. Ask what the fee covers during a paused treatment, a refund, a clinical decline or a shipment problem. Contract definitions settle these questions more reliably than a pricing slogan.

How should an established practice evaluate clinical flexibility?

An existing practice may want to keep its own licensed clinicians for current patients while extending access to patients in other locations. That creates a boundary between the practice’s existing clinical responsibilities and any external network. Define who sees which patient, where the clinical record lives, how follow-up is assigned and what happens when a patient changes location. Avoid a workflow that leaves two teams assuming the other owns an unresolved clinical question.

Karpa’s primary-care page describes using existing prescribers and network coverage where needed. Ask TEHR to demonstrate its proposed arrangement for your office rather than assuming identical functionality. The doctor-in-a-box guide explains why operating a commercial brand does not confer prescribing authority. Have both proposals name the actual clinical entities and responsibilities. Software permissions should reflect those decisions: administrative staff need useful operating visibility without the ability to override independent clinical judgment or modify a treatment decision simply to complete a sale.

What makes a patient migration credible?

A credible migration plan describes the records, current patient states and operational events that must survive the move. Patient names alone are not enough. Include active prescriptions, refill timing, clinical notes, relevant results, consent history, unresolved messages, subscription status and refunds. Identify the original care entity’s retention obligations and the destination’s authorized access. Financial portability and clinical continuity are separate problems, even when both are presented in one dashboard.

Karpa’s functional-medicine FAQ explicitly offers imports of records, active prescriptions and refill schedules. TEHR’s operators have migrated thousands of their own patients. Neither fact replaces a plan for your source system and current panel. Use the migration checklist to establish a pilot cohort, reconciliation checks, a cutover owner and rollback criteria. Ask each vendor to show the destination state of a patient due for a refill shortly after the move. That scenario exposes problems a successful file upload will not reveal.

How should you read launch and peptide-program claims?

Launch speed depends on what is already ready: website, clinical arrangements, payment approval, intake content, pharmacy routing and any required certification. A same-day configuration statement is different from a complete new-brand launch. Have the proposal identify the specific milestone and prerequisites. It should also explain what happens if a program, pharmacy relationship or third-party review is not ready on the planned date.

Karpa’s offers page gives conditional estimates of about seven or 30 days, while its practice page separately advertises same-day setup with an existing website. Resolve the scope rather than choosing the fastest statement. For TEHR, selected peptide programs remain pending and not open for prescribing or fulfillment. Review TEHR’s peptide status before planning acquisition around an offering. A vendor’s medication menu is not independent evidence of regulatory permission, and an FDA announcement does not automatically activate a program without clinical, pharmacy and operational review.

When should you choose TEHR?

Choose TEHR for evaluation when its operating approach, commercial definitions and migration plan fit the brand you intend to own. Its team’s experience with DudeMeds, Peptiders, TellyMeds and FansMeds should inform a practical demonstration of recurring customer operations. Ask about the difficult cases: a customer paying before intake is finished, a provider declining treatment, a medication change, a failed renewal and a patient needing support while an order is delayed.

TEHR should provide a clear proposal for the work it will perform and the responsibilities your team retains. It is technology and administrative infrastructure, not the medical practice making care decisions. A consistent brand experience must still contain legally required disclosures about the providers and other entities involved. Read the health-brand-in-a-box guide and choose TEHR only if the demonstrated product and contract meet the identified requirements. Do not rely on a uniqueness claim that another vendor’s public pages contradict.

When should you choose Karpa Health?

Choose Karpa for evaluation when one of its published operating paths fits your current business and expected expansion. An audience-led wellness business and a practice with existing prescribers should not receive the same requirements document merely because both want telehealth revenue. Ask the vendor to identify the exact plan, included network services, setup work and charges at your expected volume. Confirm which parts of the patient relationship remain portable if you later change models.

Karpa’s public migration description and practice-specific material make existing patient workflows worth exploring in detail. Its lab-ordering description does not mean every diagnostic service is included at no additional cost; its navigation also marks home kits as coming soon. Compare Karpa Health alternatives if your requirements center on a different implementation style. The right choice is the proposal that resolves your actual clinical, commerce and support handoffs with a sustainable cost structure, rather than the longest menu of advertised programs.

What else should you know?